Showing 2221-2230 of 3223 results for "".
- Allergan Agrees to Split CEO, Chairman Roles at Next Leadership Transitionhttps://modernod.com/news/allergan-agrees-to-split-ceo-chairman-roles-at-next-leadership-transition/2476413/Allergan disclosed in a US Securities and Exchange Commission filing on Friday that it has agreed to split its chairman and chief executive roles, both currently held by CEO Brent Saunders, at the next leadership transition. The company said that splitting the roles now, as hedge fund Appaloosa h
- Alkahest Presents Positive Phase 2a Study Results of AKST4290 for Treatment-Naïve Wet AMDhttps://modernod.com/news/alkahest-presents-positive-phase-2a-study-results-of-akst4290-for-treatment-naive-wet-amd/2476414/Alkahest shared results from its open label study, ALK4290-201. The data were delivered during a podium presentation as the Abstract Winner of the First-time Presentations of Clinical Trials and Late Breakers session at the 2019 Retina World Congress. The study evaluated the therapeutic effect an
- Novartis Plans for Alcon Spin-Off on April 9, 2019https://modernod.com/news/novartis-plans-for-alcon-spin-off-on-april-9-2019/2476408/Novartis confirmed that conditions needed for the 100% spin-off of the Alcon eye care business have been met, and the spinoff is expected to be completed on April 9, 2019. Each Novartis shareholder will receive 1 Alcon share for every 5 Novartis shares/American Deposit
- Alcon Acquires Fluid-Based IOL Maker PowerVisionhttps://modernod.com/news/alcon-announces-acquisition-of-powervision/2476387/Alcon announced that it has acquired PowerVision for $285 million plus regulatory and milestone payments starting in 2023. PowerVision’s lens design utilizes the eye’s natural accommodating response to transport fluid in the IOL. While most presbyopia-correcting IOLs use a mult
- New Study Shows an Eye Scan Can Detect Signs of Alzheimer’s Diseasehttps://modernod.com/news/new-study-shows-an-eye-scan-can-detect-signs-of-alzheimers-disease/2476384/Researchers from the Duke Eye Center have shown that a new, noninvasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers found that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer’s, and showed that the
- Allergan to Present New Data on Bimatoprost SR at the American Glaucoma Society Annual Meetinghttps://modernod.com/news/allergan-to-present-new-data-on-bimatoprost-sr-at-the-american-glaucoma-society-annual-meeting/2476377/Allergan will present new data, including a late-breaking abstract, for Bimatoprost SR at the American Glaucoma Society (AGS) meeting in San Francisco. The abstract, to be presented for the first time on March 16, is
- Major League Soccer All-Star Alecko Eskandarian to Speak at Annual NORA Conferencehttps://modernod.com/news/major-league-soccer-all-star-alecko-eskandarian-to-speak-at-annual-nora-conference/2476364/Two-time Major League Soccer (MLS) All-Star Alecko Eskandarian will be the key-note speaker at the Neuro-Optometric Rehabilitation Association, International (NORA) 28th annual General Conference (September 21-22) at the Embassy Suites by Hilton Scottsdale Resorts, Scottsdale, Arizona.
- New Data From Alcon Shows that Compliant Contact Lens Wear Can Improve Practice Outcomeshttps://modernod.com/news/new-data-from-alcon-shows-that-compliant-contact-lens-wear-can-improve-practice-outcomes/2479590/Alcon unveiled new data from its Power of One 2.0 Program showing how patient compliance with daily and monthly contact lens replacement schedules can significantly improve patient and practice outcomes. The Power of One Program is a contact lens strategy centered on 1-day and 1-month contact len
- Novartis Issues Summary Financial Information for the Alcon Eye Care Business Ahead of Shareholder Votehttps://modernod.com/news/novartis-issues-summary-financial-information-for-the-alcon-eye-care-business-ahead-of-shareholder-vote/2476260/Novartis today published certain key financial information for the Alcon eye care business covering the full year 2018 ahead of a vote on the proposed 100% spin-off of Alcon at the Novartis Annual General Meeting of Shareholders (AGM) on February 28, 2019. The issuance of the short form fi
- Allergan Responds to Public Shareholder Letterhttps://modernod.com/news/allergan-responds-to-public-shareholder-letter/2476274/Allergan issued the following statement from its Board of Directors in response to a public shareholder letter from Appaloosa hedge fund manager David Tepper earlier this week that stated the drugmaker should consider a merger or selling itself if it is “unable or unwilling to hold manageme